Cite
HARVARD Citation
Sands, B. et al. (n.d.). P312 Efficacy in biologic failure and non-biologic-failure populations in a Phase 3 study of ustekinumab in moderate–severe ulcerative colitis: UNIFI. Journal of Crohn's and colitis. pp. S256-S257. [Online].